Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N04 ANTI-PARKINSON DRUGS
N04B DOPAMINERGIC AGENTS
N04BA Dopa and dopa derivatives
N04BA02 Levodopa and decarboxylase inhibitor
D00253 Carbidopa hydrate and levodopa <JP/US>
USP drug classification [BR:br08302]
Antiparkinson Agents
Dopamine Precursors and/or L-Amino Acid Decarboxylase Inhibitors
Carbidopa/ Levodopa
D00253 Carbidopa hydrate and levodopa
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
11 Agents affecting central nervous system
116 Antiparkinsonian agents
1169 Others
D00253 Carbidopa hydrate and levodopa
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01967 Antiparkinson agent
D00253 Carbidopa hydrate and levodopa
Drug classes [BR:br08332]
Neuropsychiatric agent
DG01967 Antiparkinson agent
D00253 Carbidopa hydrate and levodopa
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D00253